⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001389221

Johnson Steven Andrew

Reports to the SEC for 1 company · IRVINE, CA

Transactions

6

Companies

1

Filings

4

CIK

0001389221

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2009-08-22	RespireRx Pharmaceuticals Inc.Options to Purchase Common StockA Award	VP, Preclinical Development	AAward	+262K sh	—	—	262,000
2009-04-13	RespireRx Pharmaceuticals Inc.S Sale	VP, Preclinical Development	SSale	−1,800 sh	$0.36	−$648	550
2009-04-13	RespireRx Pharmaceuticals Inc.S Sale	VP, Preclinical Development	SSale	−200 sh	$0.37	−$74	350
2009-04-13	RespireRx Pharmaceuticals Inc.S Sale	VP, Preclinical Development	SSale	−350 sh	$0.38	−$133	0
2008-05-30	RespireRx Pharmaceuticals Inc.A Award	VP, Preclinical Development	AAward	+11K sh	$0.78	+$8,589.36	22,012
2008-01-18	RespireRx Pharmaceuticals Inc.Options to Purchase Common StockA Award	VP, Preclinical Development	AAward	+100K sh	—	—	100,000

Recent filings

4

Accepted (ET)
Feb 25
Johnson Steven Andrew0001181431-10-006150
SEC(opens sec.gov)
Aug 244
Johnson Steven Andrew0001181431-09-040976
SEC(opens sec.gov)
Jun 24
CORTEX PHARMACEUTICALS INC/DE/0001181431-08-035918
SEC(opens sec.gov)
Jan 224
CORTEX PHARMACEUTICALS INC/DE/0001181431-08-004675
SEC(opens sec.gov)

Companies

1

RespireRx Pharmaceuticals Inc.VP, Preclinical Development

Address

15241 BARRANCA PARKWAY

IRVINE, CA, 92618